Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054732
Filing Date
2021-11-05
Accepted
2021-11-05 07:07:49
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q srra-10q_20210930.htm   iXBRL 10-Q 2645717
2 EX-10.1 srra-ex101_105.htm EX-10.1 561282
3 EX-31.1 srra-ex311_9.htm EX-31.1 9805
4 EX-31.2 srra-ex312_6.htm EX-31.2 9808
5 EX-32.1 srra-ex321_8.htm EX-32.1 7254
6 EX-32.2 srra-ex322_7.htm EX-32.2 7316
  Complete submission text file 0001564590-21-054732.txt   8622402

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA srra-20210930.xsd EX-101.SCH 49162
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20210930_cal.xml EX-101.CAL 43510
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20210930_def.xml EX-101.DEF 151212
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20210930_lab.xml EX-101.LAB 385762
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20210930_pre.xml EX-101.PRE 277158
12 EXTRACTED XBRL INSTANCE DOCUMENT srra-10q_20210930_htm.xml XML 1359890
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 211382305
SIC: 2834 Pharmaceutical Preparations